Evidence map›Paper›PMID 34631576›Full record

ArticleFrontiers in oncology2021

Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function.

Thomas Briston, Jenna M Stephen, Luke W Thomas, Cinzia Esposito, Yuen-Li Chung, Saiful E Syafruddin, Mark Turmaine, Lucas A Maddalena, Basma Greef, Gyorgy Szabadkai and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Thomas BristonDivision of Medicine, Centre for Cell Signalling and Molecular Genetics, University College London, London, United Kingdom.
Jenna M StephenDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Luke W ThomasDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Cinzia EspositoDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Yuen-Li ChungCancer Research UK Cancer Imaging Centre, Institute of Cancer Research London, London, United Kingdom.
Saiful E SyafruddinMedical Research Council Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
Mark TurmaineDivision of Biosciences, Department of Cell and Developmental Biology, University College London, London, United Kingdom.
Lucas A MaddalenaDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Basma GreefDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Gyorgy SzabadkaiDivision of Biosciences, Department of Cell and Developmental Biology, University College London, London, United Kingdom.
Patrick H MaxwellCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Sakari VanharantaMedical Research Council Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
Margaret AshcroftDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2018.00388.].

Indexed as

bioenergeticsCHCHD4Hippel-Lindau protein (pVHL)hypoxia inducible factormetabolismmitochondriarespiratory chain

Identifiers

PMID34631576
PMCPMC8496443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.